NeueHealth Earnings Reports

NeueHealth achieved strong fourth-quarter results, with $232.64 million in revenue and net income of $2.52 million. The company reported positive adjusted EBITDA for the fourth consecutive quarter, highlighting the success of its value-driven, consumer-centric care model.

NeueHealth reported strong financial results for Q3 2024, driven by positive momentum in NeueCare and NeueSolutions. The company achieved Adjusted EBITDA profitability for the third consecutive quarter and reaffirmed its full-year Adjusted EBITDA guidance.

NeueHealth reported solid Q2 2024 results with positive Adjusted EBITDA for the second consecutive quarter. The company is reaffirming Adjusted EBITDA guidance for the full year and expects to reach the high end of the guidance range for consumers served by year-end.

NeueHealth reported a revenue of $245.1 million and a net income from continuing operations of $5.7 million for Q1 2024. The company is maintaining its expectation for 2024 Adjusted EBITDA of between $15 million and $25 million.

NeueHealth reported Q4 and full year 2023 results, highlighting a focus on care delivery and provider enablement after the sale of the California Medicare Advantage business. The NeueHealth business drove strong results in 2023, delivering $1.2 billion in revenue, up 55% year over year, and serving 461,000 consumers across the country.

Bright Health Group reported a 39% year-over-year increase in revenue from continuing business, reaching $269.4 million. The company achieved positive Adjusted EBITDA of $1.2 million, marking its second consecutive quarter of profitability on this metric. However, the company reported a net loss of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge.

Bright Health Group reported Q2 2023 results, featuring a 100% year-over-year revenue increase from continuing business, reaching $298.0 million. The company achieved positive Adjusted EBITDA of $6.4 million and positive operating income in both Care Delivery and Care Solutions segments. They are maintaining expectations for 2023 consolidated Adjusted EBITDA profitability.

Bright Health Group reported a 23% year-over-year increase in revenue from continuing business, reaching $756.3 million. The Consumer Care segment achieved positive operating income, and the California MCR was 89.0%, excluding prior period medical costs. The company maintains its expectation for 2023 consolidated Adjusted EBITDA profitability.

Bright Health Group reported Q4 2022 results with revenue of $551.4 million and a net loss of $188.2 million. The company is focusing on its Consumer Care and Bright HealthCare segments after exiting its ACA insurance business.

Bright Health Group reported a revenue of $1.6 billion, a 51.3% increase from Q3 2021. The company experienced a GAAP Net Loss of $259.4 million and an Adjusted EBITDA Loss of $82.9 million. They are lowering the Full Year 2022 Enterprise Medical Cost Ratio guidance range to 90% to 92% and positively revising the Full Year 2022 Adjusted EBITDA loss guidance range to $550 to $700 million.

Bright Health Group reported a revenue of $1.6 billion, up 41.5% from Q2'21. The GAAP Net Loss was $251.3 million, and the Adjusted EBITDA Loss was $194.9 million. The Enterprise Medical Cost Ratio was 88.8%. The company reaffirmed its 2022 Consolidated Revenue, MCR, and Adjusted EBITDA guidance.

Bright Health Group reported a revenue of $1.8 billion, up 109.9% from Q1'21. The GAAP Net Loss was $180.6 million and the Adjusted EBITDA loss was $74.8 million. The company served 1.16 million Bright HealthCare members and over 530,000 NeueHealth value-based patients.

Bright Health Group reported a Q4 2021 revenue of $962.3 million, a 167.5% increase year-over-year. However, the company experienced a GAAP Net Loss of $813.4 million and an Adjusted EBITDA loss of $790.1 million.